UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Үндсэн зохиолчид: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2017
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
-н: Hanna, G, зэрэг
Хэвлэсэн: (2016) -
Stereotactic body radiotherapy for liver metastases.
-н: Aitken, K, зэрэг
Хэвлэсэн: (2015) -
Stereotactic body radiotherapy for oligometastases.
-н: Tree, A, зэрэг
Хэвлэсэн: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
-н: Khoo, V, зэрэг
Хэвлэсэн: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
-н: Khoo, V, зэрэг
Хэвлэсэн: (2017)